Many therapies fail to meet real-world expectations because they are designed for the lab, not life. Innovations focus on clinical efficacy, which drives only 20% of health outcomes, while ignoring the 80% driven by crucial psychological, social, and environmental factors.

The medical establishment's fear of lawsuits over acute events (like a fatal low blood sugar incident) leads to diabetes management strategies that prevent short-term disasters but allow long-term, debilitating complications like blindness. This incentive misalignment suppresses simpler, more effective dietary solutions that could improve quality of life.

Medicine excels at following standardized algorithms for acute issues like heart attacks but struggles with complex, multifactorial illnesses that lack a clear diagnostic path. This systemic design, not just individual doctors, is why complex patients often feel lost.

The current medical model, which treats diseases one by one as they appear, is flawed for an aging population. It extends life but leads to a rise in overall frailty and disability. The only effective path forward is to directly target the underlying biological process of aging to extend healthspan.

The goal isn't for AI to replicate a doctor's thought process, which is constrained by human limitations. Instead, AI should leverage its superior data processing to be fundamentally "truth-seeking," even if it means a longer path to regulatory approval for tasks like prescribing medications.

Dr. Smith argues that while drugs are essential for acute emergencies like heart attacks or broken bones, they are ill-suited for chronic problems. For long-term issues, focusing on root causes is more effective than continuous symptom management with medication.

The traditional medical ethos prevents interventions on non-sick patients. This conservative approach may be irrational when low-risk therapies could add decades of healthy life, challenging the fundamental definition of when a doctor should act.

Chronic illnesses like cancer, heart disease, and Alzheimer's typically develop over two decades before symptoms appear. This long "runway" is a massive, underutilized opportunity to identify high-risk individuals and intervene, yet medicine typically focuses on treatment only after a disease is established.

Healthcare systems were designed for acute, symptomatic diseases. This "wait for the patient" model is ineffective for chronic conditions like hypertension, which are often asymptomatic for years. The future requires a shift from sporadic visits to continuous, proactive, tech-enabled care.